Patent AT-E401416-T1: [Translated] METHOD FOR PRODUCING OPTICALLY ACTIVE N-PROTECTED PROPARGYLGLYCINE
A method for producing (S)-N-protected-propargylglycine of the following formula (2), which comprises asymmetrically hydrolyzing an N-protected-propargylglycine of the following formula (1): nwherein R 1 represents an alkyl group having 1 to 4 carbon atoms, R 2 and R 3 each independently represent a hydrogen atom or a protective group of an amino group, R 2 and R 3 being not simultaneously a hydrogen atom, and a carbon atom appended with a mark * represents an asymmetric carbon atom, nusing an asymmetric hydrolysis enzyme derived from a microorganism selected from Thermomyces genus, Aspergillus genus, Rhizopus genus, Penicillium genus, Pseudomonas genus, Humicola genus, Burkholderia genus, Candida genus and Streptomyces genus, or a cultured substance of a microorganism having an ability of producing this enzyme or a treated substance thereof, nor using an asymmetric hydrolysis enzyme which is ±-amylase derived from a microorganism selected from Bacillus subtilis and Bacillus licheniformis.
Complete Metadata
| bureauCode |
[ "009:25" ] |
|---|---|
| identifier | https://healthdata.gov/api/views/y279-z8at |
| issued | 2025-09-05 |
| landingPage | https://healthdata.gov/d/y279-z8at |
| programCode |
[ "009:066" ] |
| theme |
[ "NIH" ] |